Single-arm, Prospective Clinical Trial of Efficacy and Safety of Daphnetin Capsules Combined With TC Regimen for Targeted Maintenance Therapy After Initial Treatment of Stage III-IV Epithelial Ovarian Cancer (RO/R1)

NCT07495397 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Epithelial Ovarian Cancer

Interventions

DRUG: Daphne Extract Capsules

Sponsor

The First Hospital of Jilin University